students and professor
UTSA Honors College students with Professor Thomas Forsthuber

Neuroscience firm donates to Honors College

By Kris Rodriguez
Public Affairs Specialist

(Oct. 17, 2007)--The UTSA Honors College received $3,200 from Teva Neuroscience, a Kansas City based company that helps people with neurological disorders live more independent lives.

The donation was used to purchase 64 stethoscopes for Honors College students in the course, Introduction to Clinical Medicine, taught by Thomas Forsthuber, UTSA professor and holder of the Jesse H. and Mary Gibbs Jones Endowed Chair in Biotechnology.

The class is an introduction to clinical medicine and the pathology of important human diseases. Students learn about basic pathological mechanisms of human diseases at the level of cells, organs and organ systems, how to recognize the diseases and current treatments.

"I was very pleased that Teva Neuroscience was so generous in supporting our UTSA students, and I am sure they will put them to good use on their way to becoming compassionate doctors," said Forsthuber. "It was extremely rewarding to see the surprise and joy of the students when they received these stethoscopes."

Forsthuber's research in developing a novel type of treatment for Multiple Sclerosis patients is funded through a $510,000 grant by the National Multiple Sclerosis. Over his 15-year career studying MS, Forsthuber has received three National MS Society grants, including his most recent, a first for the San Antonio community.

He also is a faculty member with the UTSA South Texas Center for Emerging Infectious Diseases (STCEID), one of the leading emerging infectious disease research centers in the country. Since opening in 2005, the center has generated more than $5.3 million in research funding from the National Institutes of Health and private organizations.

With 19 research teams, STCEID researchers focus on critical areas of human health including anthrax, tularemia, cholera, Lyme disease, desert valley fever, and other bacterial and fungal diseases.

University Communications
Contact Us

text size | + | R |